Procalcitonin as a Predictor of Septic Knee Arthritis: A Retrospective Cohort Study
- PMID: 37450766
- PMCID: PMC9831185
- DOI: 10.5435/JAAOSGlobal-D-22-00261
Procalcitonin as a Predictor of Septic Knee Arthritis: A Retrospective Cohort Study
Abstract
Introduction: Differentiating septic arthritis from aseptic arthritis (AA) of the knee is difficult without arthrocentesis. Although procalcitonin (PCT) has shown diagnostic value in identifying bacterial infections, it has not been established as a reliable marker for identifying septic arthritis (SA). Recent studies have shown promise in the use of PCT as a useful systemic marker for identifying septic arthritis versus AA. This observational retrospective review compares PCT with routine inflammatory markers as a tool for differentiating septic arthritis versus AA in patients with acute, atraumatic knee pain.
Methods: Fifty-three consecutive patients (24 SA, 29 AA) were retrospectively reviewed at one institution with concern for SA. SA was diagnosed based on a physical examination, laboratory markers, and arthrocentesis. Laboratory indices were compared between the septic arthritis and AA groups. Data analysis was conducted to define sensitivity and specificity. Receiver operator characteristic curve analysis and regression were conducted to determine the best marker for acute SA of the knee.
Results: Using multiple logistic regression, bacteremia (OR 6.75 ± 5.75) was determined to be the greatest predictor of SA. On linear regression, concomitant bacteremia (coef 3.07 ± 0.87), SA (coef 2.18 ± 0.70), and the presence of pseudogout crystals (coef 1.80 ± 0.83) on microscopy predicted an increase in PCT. Using a PCT cutoff of 0.25 ng/mL yields a sensitivity of 91.7% and specificity of 55.2% for predicting SA; however, the ideal cutoff in our series was 0.32 ng/mL with a sensitivity of 79.2% and specificity of 72.4%. PCT was superior to the white blood cell count, erythrocyte sedimentation rate, and C-reactive protein in the area under the receiver-operating characteristic curve analysis.
Discussion: Procalcitonin seems to be the most sensitive and specific systemic marker in differentiating septic from AA.
Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Orthopaedic Surgeons.
Figures
Similar articles
-
Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis.Int J Rheum Dis. 2015 Mar;18(3):352-9. doi: 10.1111/1756-185X.12496. Epub 2014 Dec 3. Int J Rheum Dis. 2015. PMID: 25469944
-
Serum Procalcitonin is a sensitive and specific marker in the diagnosis of septic arthritis and acute osteomyelitis.J Orthop Surg Res. 2013 Jul 4;8:19. doi: 10.1186/1749-799X-8-19. J Orthop Surg Res. 2013. PMID: 23826894 Free PMC article.
-
Procalcitonin as a diagnostic aid in osteomyelitis and septic arthritis.Pediatr Emerg Care. 2005 Dec;21(12):828-32. doi: 10.1097/01.pec.0000190226.12610.24. Pediatr Emerg Care. 2005. PMID: 16340758
-
The value of procalcitonin measurement in localized skin and skin structure infection, diabetic foot infections, septic arthritis and osteomyelitis.Expert Rev Mol Diagn. 2014 Jan;14(1):47-54. doi: 10.1586/14737159.2014.864238. Epub 2013 Dec 2. Expert Rev Mol Diagn. 2014. PMID: 24308337 Review.
-
Is serum procalcitonin measurement a useful addition to a rheumatologist's repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections.Rheumatology (Oxford). 2015 Feb;54(2):231-40. doi: 10.1093/rheumatology/keu416. Epub 2014 Oct 27. Rheumatology (Oxford). 2015. PMID: 25349443 Review.
Cited by
-
Comparative Outcomes of Arthroscopic versus Open Surgical Approaches in the Management of Septic Arthritis of the Knee: A Retrospective Study.J Orthop Case Rep. 2025 May;15(5):300-304. doi: 10.13107/jocr.2025.v15.i05.5638. J Orthop Case Rep. 2025. PMID: 40351628 Free PMC article.
-
Comparative Characterization of Procalcitonin (Sensitivity, Specificity, Predictability, and Cut-Off Reference Values) as a Marker of Inflammation in Odontogenic Abscesses of the Head and Neck in the Female Population.Cureus. 2023 Nov 3;15(11):e48207. doi: 10.7759/cureus.48207. eCollection 2023 Nov. Cureus. 2023. PMID: 38050495 Free PMC article.
References
-
- Hugle T, Schuetz P, Mueller B, et al. : Serum procalcitonin for discrimination between septic and non-septic arthritis. Clin Exp Rheumatol 2008;26:453-456. - PubMed
-
- Shao Y, Zhang C, Charron KD, Macdonald SJ, Mccalden RW, Bourne RB: The fate of the remaining knee ( s ) or hip (s) in osteoarthritic patients undergoing a primary TKA or THA. The J Arthroplasty 2013;28:1842-1845. - PubMed
-
- Sloan M, Premkumar A, Sheth NP: Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg 2018;100:1455-1460. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials